Viracta Therapeutics Overview

Viracta Therapeutics Research & Development

Research & Development expenses for VIRX.

Quarterly R&D Expenses

$7.18M

↓ 11.98% YoY

As of Sep 30, 2024

Annual R&D Expenses (TTM)

$33.09M

↑ 7.91% YoY

Trailing 12 months ending Sep 30, 2024

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin